about
Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cellsDefective production of interleukin-11 by decidua and chorionic villi in human anembryonic pregnancyExpression of leukemia inhibitory factor and its receptor in preimplantation embryos.Factors from human embryonic stem cell-derived fibroblast-like cells promote topology-dependent hepatic differentiation in primate embryonic and induced pluripotent stem cells.Epithelial cell adhesion molecule (EpCAM) complex proteins promote transcription factor-mediated pluripotency reprogramming.Loss of non-coding RNA expression from the DLK1-DIO3 imprinted locus correlates with reduced neural differentiation potential in human embryonic stem cell lines.Granulosa cell-derived induced pluripotent stem cells exhibit pro-trophoblastic differentiation potential.Functional microarray analysis of differentially expressed genes in granulosa cells from women with polycystic ovary syndrome related to MAPK/ERK signaling.Suppression of the SOX2 neural effector gene by PRDM1 promotes human germ cell fate in embryonic stem cells.Current opinion on use of luteinizing hormone supplementation in assisted reproduction therapy: an Asian perspective.Differentiation of human embryonic stem cells into functional ovarian granulosa-like cells.Hypoxic culture maintains self-renewal and enhances embryoid body formation of human embryonic stem cells.Decoy receptor 3 expression during the menstrual cycle and pregnancy, and regulation by sex steroids in endometrial cells in vitro.A reduced oxygen tension (5%) is not beneficial for maintaining human embryonic stem cells in the undifferentiated state with short splitting intervals.Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation.Human Pompe disease-induced pluripotent stem cells for pathogenesis modeling, drug testing and disease marker identification.Increased follistatin levels after oral contraceptive treatment in obese and non-obese women with polycystic ovary syndrome.Novel autogenic feeders derived from human embryonic stem cells (hESCs) support an undifferentiated status of hESCs in xeno-free culture conditions.Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration.Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis.Expression of leukemia inhibitory factor and its receptor is not altered in the decidua and chorionic villi of human anembryonic pregnancy.Validating a rapid, real-time, PCR-based direct mutation detection assay for preimplantation genetic diagnosis.Granulosa cells and retinoic acid co-treatment enrich potential germ cells from manually selected Oct4-EGFP expressing human embryonic stem cells.Blastocyst morphology score as an indicator of embryo competence for women aged younger than 38 years in in vitro fertilization cycles.Surface marker epithelial cell adhesion molecule and E-cadherin facilitate the identification and selection of induced pluripotent stem cells.The relationship between follistatin and chronic low-grade inflammation in women with polycystic ovary syndromeAssociation of a single dose of gonadotropin-releasing hormone antagonist with nitric oxide and embryo quality in in vitro fertilization cyclesHuman peripheral blood mononuclear cells express gonadotropin-releasing hormone (GnRH), GnRH receptor, and interleukin-2 receptor gamma-chain messenger ribonucleic acids that are regulated by GnRH in vitro
P50
Q24338783-C29DF33E-E6B0-4A0C-8B50-2EE3B5BFB5B9Q28216759-1D21E01E-FD0B-4152-8A00-84CFB1D7303CQ33876918-2EE237AE-52AE-493A-90A1-DFDDCFD95381Q34236560-C39E3B07-08D6-465F-8AE1-06B3CA8EBD82Q35312062-AC11B7CA-D6F3-4C3E-8A3D-7B2ECA34361CQ35562665-D9375F64-CD57-42BF-A748-54D272C9D8EBQ35604274-37DB7C2E-1401-499C-97B2-44E51A83CBD9Q36150037-0C516460-A9A8-455D-8A2A-0E33A6BEDA47Q37581642-366325F5-5BE8-46F7-B09E-D12B3E30956FQ37873186-01B7D3E4-4673-49EA-AB83-8FEAC53E2B01Q39120660-351785DB-CBCC-4806-A34B-D6F2B354B0E1Q39695358-77679C6A-937A-464E-B286-2ABF5F8C8C9FQ39879293-9ABF198D-A7B7-490C-80C3-63319B0D8CC4Q39935344-582C0AA3-0C5A-41C5-8F84-B29DD6E20907Q42805647-A32AA5C2-1FAF-4A6D-B062-4CC0A8F8A6BAQ42817633-F3099353-C3A8-4FCE-9F26-5F7389F7E6D3Q43186682-1196D396-CA39-41A7-BD64-633335B6E65EQ46128962-CE77AFEE-D6C1-4AA1-95BC-8950A131E137Q46541128-83A3B8CC-3694-4DFF-BC87-983B68B0E42CQ47289744-CDAA12A5-C215-4588-8786-766E2C119D23Q47387080-949D5A2D-4178-4373-BC4C-928718E6EA9BQ48252674-4ABA18D9-9C57-41D1-8B18-AD4842D81B5DQ50452567-812713B0-BEEA-4072-975F-D2F7FF2B9E4FQ51199520-59368D40-6A9A-493B-951B-01DEF8B29726Q53269381-3A2B986D-38B5-4454-A590-41242423004FQ58377140-1D25C1A0-4AA1-4FE4-8169-EE769204DFBAQ58377149-167302C3-4A0F-4E1D-9BEE-B4DCBD006531Q74449570-6BE4747A-8891-4B38-A762-0C01BC38F5B1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Hsin-Fu Chen
@ast
Hsin-Fu Chen
@en
Hsin-Fu Chen
@es
Hsin-Fu Chen
@nl
Hsin-Fu Chen
@sl
type
label
Hsin-Fu Chen
@ast
Hsin-Fu Chen
@en
Hsin-Fu Chen
@es
Hsin-Fu Chen
@nl
Hsin-Fu Chen
@sl
altLabel
陳信孚
@en
prefLabel
Hsin-Fu Chen
@ast
Hsin-Fu Chen
@en
Hsin-Fu Chen
@es
Hsin-Fu Chen
@nl
Hsin-Fu Chen
@sl
P108
P106
P1153
35336208600
P31
P496
0000-0002-7748-4440